NASDAQ · Medical - Healthcare Information Services

NRC (NRC) Stock

$18.30 -18.08% NASDAQ: NRC Healthcare

Valuation

MetricValue
Price$18.30
Market Cap$412.42M
P/E Ratio36.21
P/B Ratio30.31
P/S Ratio3.05
EPS (TTM)$0.52
52-Week High$22.98
52-Week Low$11.01
Dividend Yield2.98%

Financials & Margins

MetricValue
ROE85.71%
ROA8.89%
ROCE164.29%
Gross Margin16.06%
Operating Margin16.79%
Net Margin6.52%
Debt/Equity5.78
Current Ratio0.54

Annual Financials (USD)

Metric20212022202320242025
Revenue$148.0M$152.0M$149.0M$143.0M$137.0M
Operating Profit$50.0M$47.0M$40.0M$35.0M$23.0M
Net Profit$37.0M$32.0M$31.0M$25.0M$12.0M
EPS$1.46$1.27$1.25$1.04$0.52
Op Margin34.0%30.7%26.9%24.6%16.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$158.0M$130.0M$122.0M$133.0M$135.0M
Total Liabilities$72.0M$58.0M$73.0M$101.0M$121.0M
Cash$54.0M$25.0M$7.0M$4.0M$4.0M
Borrowings$29.0M$23.0M$39.0M$64.0M$79.0M

Latest News

NRC Health and Healthcare Experience Foundation Launch Strategic Partnership to Deepen Support for Improving Experience, Safety, and Workforce Engagement Business Wire · Jun 9, 2026 There May Be Reason For Hope In NRC Health's (NASDAQ:NRC) Disappointing Earnings Simply Wall St. · May 13, 2026 NRC Health's Q1 Earnings Fall Y/Y Due to Elevated Operating Costs Zacks · May 1, 2026 NRC Health (NRC) Q1 2026 Earnings Call Highlights: Record TRCV and Landmark Deals Propel Growth GuruFocus.com · Apr 29, 2026 National Research Q1 Earnings Call Highlights MarketBeat · Apr 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$46.0M$36.0M$38.0M$35.0M$26.0M
Investing Cash Flow$-14.0M$-20.0M$-32.0M$-36.0M$-21.0M
Financing Cash Flow$-4.0M$-30.0M$-19.0M$-31.0M$-21.0M
Net Cash Flow$20.0M$-29.0M$-18.0M$-2.0M$0
Free Cash Flow$41.0M$26.0M$22.0M$19.0M$16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA16.11
FCF Yield4.12%
Quick Ratio0.52
Interest Coverage4.60
Return 1Y46.34%
Return 3Y-47.23%
Return 5Y-49.65%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
DH $0.67 -1.38% 4.29 $71.08M 0.00%
HCAT $2.16 +0.93% -0.54 $159.61M 0.00%
NNOX $1.06 +3.92% -1.56 $73.78M 0.00%
PBYI $8.91 +9.73% 11.46 $453.51M 0.00%
QTRX $3.38 -3.15% -1.00 $159.22M 0.00%

About NRC

NRC is led by CEO Trent Green, employs 368 people, headquartered in US, publicly traded since 2013.

NRC stock trades at $18.30 with a market capitalization of $412.42M. The stock is valued at a price-to-earnings (P/E) ratio of 36.21, price-to-book of 30.31, price-to-sales of 3.05. Over the past 52 weeks the stock has ranged between $11.01 and $22.98, and currently trades 20.4% below its 52-week high. It pays a dividend yielding 2.98%.

On profitability, NRC generates a return on equity (ROE) of 85.71% — well above the market average, a sign of a high-quality business, return on capital employed of 164.29%, an operating margin of 16.79%, a net profit margin of 6.52%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides